RADIOLABELLED GRPR-ANTAGONIST FOR USE AS THERAGNOSTIC

The present disclosure relates to gastrin-releasing peptide receptor (GRPR) targeting pharmaceuticals and their use in a theragnostic approach for selection and therapy of subjects with GRPR-expressing malignancies. In particular, the present disclosure relates to a pharmaceutical composition of a r...

Full description

Saved in:
Bibliographic Details
Main Authors WEGENER, Antje, ORLANDI, Francesca, MARIANI, Maurizio F, CHICCO, Daniela
Format Patent
LanguageEnglish
French
Published 01.04.2021
Subjects
Online AccessGet full text

Cover

Loading…